2014 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute
2012 - Fellow, National Academy of Inventors
2012 - Robert J. and Claire Pasarow Foundation Medical Research Award
2002 - Member of the National Academy of Medicine (NAM)
1998 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
1998 - Sedgwick Memorial Medal, American Public Health Association
1996 - Metlife Foundation Award for Medical Research in Alzheimer's Disease
Member of the Association of American Physicians
John Q. Trojanowski focuses on Pathology, Alzheimer's disease, Neuroscience, Dementia and Disease. His studies deal with areas such as Central nervous system and Traumatic brain injury as well as Pathology. His Alzheimer's disease research incorporates elements of Biomarker, Neuroimaging and Cerebrospinal fluid.
The various areas that John Q. Trojanowski examines in his Neuroscience study include Genetically modified mouse and Neurodegeneration, Tauopathy. His Dementia study integrates concerns from other disciplines, such as Pathological, Parkinson's disease, Parkinsonism, Neurology and Atrophy. In the field of Disease, his study on Senile plaques overlaps with subjects such as Extramural.
Pathology, Disease, Alzheimer's disease, Neuroscience and Dementia are his primary areas of study. His Disease research includes themes of Pathological, Oncology and Clinical trial, Bioinformatics. His Alzheimer's disease study incorporates themes from Amyloid and Degenerative disease.
His Neuroscience research is multidisciplinary, relying on both Neurodegeneration and Tauopathy. His Dementia study combines topics in areas such as Neuropathology and Psychiatry, Cognition. As a part of the same scientific study, John Q. Trojanowski usually deals with the Internal medicine, concentrating on Neuroimaging and frequently concerns with Alzheimer's Disease Neuroimaging Initiative.
His main research concerns Disease, Pathology, Internal medicine, Neurodegeneration and Neuroscience. His research integrates issues of Cerebrospinal fluid and Neuroimaging in his study of Disease. All of his Pathology and Frontotemporal lobar degeneration, Neuropathology, Lewy body, Atrophy and Tauopathy investigations are sub-components of the entire Pathology study.
John Q. Trojanowski combines subjects such as Endocrinology and Oncology with his study of Internal medicine. The concepts of his Neurodegeneration study are interwoven with issues in Neuroinflammation and Pathological. His work carried out in the field of Neuroscience brings together such families of science as Amyotrophic lateral sclerosis and Microglia.
His main research concerns Disease, Pathology, Alzheimer's disease, Internal medicine and Neuroscience. His Disease research is multidisciplinary, incorporating elements of Cognition, Pathological and Neuroimaging. His Frontotemporal lobar degeneration, Neuropathology, Neurodegeneration, Lewy body and Parkinson's disease investigations are all subjects of Pathology research.
He has included themes like Bioinformatics, Atrophy and Cognitive decline in his Alzheimer's disease study. His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Oncology. His Neuroscience research integrates issues from Progressive supranuclear palsy, Intracellular, Microglia and Tauopathy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
α-Synuclein in Lewy bodies
Maria Grazia Spillantini;Marie Luise Schmidt;Virginia M.-Y. Lee;John Q. Trojanowski.
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann;Deepak M. Sampathu;Linda K. Kwong;Adam C. Truax.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R Jack;David S Knopman;William J Jagust;Leslie M Shaw.
Lancet Neurology (2010)
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
M. Hutton;C. L. Lendon;P. Rizzu;M. Baker.
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack;David S Knopman;William J Jagust;Ronald C Petersen.
Lancet Neurology (2013)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
Curt R. Freed;Paul E. Greene;Robert E. Breeze;Wei-Yann Tsai.
The New England Journal of Medicine (2001)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman;G. K. Wenning;P. A. Low;D. J. Brooks.
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
Bradley T. Hyman;John Q. Trojanowski.
Journal of Neuropathology and Experimental Neurology (1997)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.
Carlo Ballatore;Virginia M.-Y. Lee;John Q. Trojanowski.
Nature Reviews Neuroscience (2007)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: